Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol

BACKGROUND: Population-based studies suggest that emergency department visits and hospitalizations are common among patients receiving chemotherapy and that rates in routine practice are higher than expected from clinical trials. Chemotherapy-related toxicities are often predictable and, consequentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Krzyzanowska, Monika K., Julian, Jim A., Powis, Melanie, Howell, Doris, Earle, Craig C., Enright, Katherine A., Mittmann, Nicole, Trudeau, Maureen E., Grunfeld, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6729066/
https://www.ncbi.nlm.nih.gov/pubmed/31488084
http://dx.doi.org/10.1186/s12885-019-6099-x

Ejemplares similares

Ejemplares similares